000			01511 a2200457 4500
005			20250518092037.0
264		0	_c20210329
008			202103s 0 0 eng d
022			_a2211-0356
024	7		_a10.1016/j.msard.2020.102045 _2doi
040			_aNLM _beng _cNLM
100	1		_aAmaral, Juliana Mss
245	0	0	_aOptic neuritis at disease onset predicts poor visual outcome in neuromyelitis optica spectrum disorders. _h[electronic resource]
260			_bMultiple sclerosis and related disorders _cJun 2020
300			_a102045 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeuromyelitis Optica _xdrug therapy
650	0	4	_aOptic Neuritis _xdrug therapy
650	0	4	_aOutcome Assessment, Health Care
650	0	4	_aRecurrence
650	0	4	_aRetrospective Studies
650	0	4	_aSeverity of Illness Index
650	0	4	_aSteroids _xtherapeutic use
650	0	4	_aTime Factors
650	0	4	_aYoung Adult
700	1		_aTalim, Natália
700	1		_aKleinpaul, Rodrigo
700	1		_aLana-Peixoto, Marco A
773	0		_tMultiple sclerosis and related disorders _gvol. 41 _gp. 102045
856	4	0	_uhttps://doi.org/10.1016/j.msard.2020.102045 _zAvailable from publisher's website
999			_c30748347 _d30748347